Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects.

Trivedi, Ashit; Sohn, Winnie; Jafarinasabian, Pegah; Zhang, Hanze; Terminello, Bianca; Flach, Stephen; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward

Trivedi, Ashit; Sohn, Winnie; Jafarinasabian, Pegah; Zhang, Hanze; Terminello, Bianca; Flach, Stephen; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward.

Trivedi A; Amgen Inc, Thousand Oaks, California, USA.
Sohn W; Amgen Inc, Thousand Oaks, California, USA.
Jafarinasabian P; Amgen Inc, Thousand Oaks, California, USA.
Zhang H; Amgen Inc, Thousand Oaks, California, USA.
Terminello B; Amgen Inc, Thousand Oaks, California, USA.
Flach S; Covance Inc, Madison, Wisconsin, USA.
Abbasi S; Amgen Inc, Thousand Oaks, California, USA.
Dutta S; Amgen Inc, Thousand Oaks, California, USA.
Lee E; Amgen Inc, Thousand Oaks, California, USA.

Clin Pharmacol Drug Dev ; 11(1): 129-133, 2022 01.

Article en En | MEDLINE | ID: mdl-34272833

Asunto(s)

Omeprazol; Inhibidores de la Bomba de Protones; Interacciones Farmacológicas; Voluntarios Sanos; Humanos; Omeprazol/efectos adversos; Omeprazol/farmacocinética; Inhibidores de la Bomba de Protones/efectos adversos; Inhibidores de la Bomba de Protones/farmacocinética; Urea/análogos & derivados

Palabras clave

drug-drug interaction; omecamtiv mecarbil; pharmacokinetics; proton pump inhibitor

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Omeprazol / Inhibidores de la Bomba de Protones Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google